Phase 2a RDEA3170 and Allopurinol Combination Study in Gout Subjects

Trial Identifier: RDEA3170-206
Sponsor: Ardea Biosciences, Inc.
Start Date: July 2015
Primary Completion Date: December 2015
Condition: Immune, Inflammatory & Infections - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
Spanish Translation
English Translation

Trial Locations

Country Location
USA, CA Anaheim, CA, USA, 92801
USA, FL DeLand, FL, USA, 32720
USA, FL South Miami, FL, USA, 33143
USA, TX Dallas, TX, USA, 75231